<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <p>This work was supported by funds from the ARN grant Labex ‘Integrative Biology of Emerging Infectious Diseases’ (grant number ANR-10-LABX-62-IBEID) from the French Government’s ‘Investissement d’Avenir’ programme, and from the PREDEMICS consortium (grant agreement number 278433) from the European Community Seventh Framework Programme FP7/2007–2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are very grateful to G. Brownlee for providing the pPOLI expression plasmids of influenza virus A/WSN/33 and to J. Pavlovic for the four pHMG recombinant plasmids of influenza virus A/PR/8/34, and wish to thank C. Isel-Griffiths, S. Munier and M. Declercq for helpful discussions and critical reading of the manuscript.</p>
</ack>
